Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01731496 · ClinicalTrials.gov registry record · NA
The Efficacy of Reminders to Complete HPV Series
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 749
- Enrollment target
NCT01731496 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 749 participants.
The verdict
NCT01731496, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 749 participants
- Enrollment target
Study Summary
The human papillomavirus (HPV) vaccine is routinely recommended for both adolescent girls and boys starting at age 11, although it can be offered as young as 9 years of age. This is a 3-dose series and many adolescents do not complete it after getting the first dose. This study will study how effective it will be to send reminders to parents to schedule an appointment when their child is due for the next dose of HPV. Parents can chose whether they would like a phone call or text message reminder. This study will determine if the reminders work, and if one method is better than another (phone message vs. text message).
Interventions
- OTHER Telephone reminder
- OTHER Text Message reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 749 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01731496
The ClinicalTrials.gov registry entry for NCT01731496 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 749 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Telephone reminder is the first listed.
NCT01731496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01731496 about?
NCT01731496 is a clinical study titled "The Efficacy of Reminders to Complete HPV Series". The human papillomavirus (HPV) vaccine is routinely recommended for both adolescent girls and boys starting at age 11, although it can be offered as young as 9 years of age. This is a 3-dose series and many adolescents do not complete it after getting the first dose. This study will study how effect...
What is the current status of trial NCT01731496?
This trial is currently completed. It is a NA study. The enrollment target is 749 participants. The study started on 2012-04. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01731496?
The interventions under investigation include: Telephone reminder (OTHER), Text Message reminder (OTHER).
Who is sponsoring clinical trial NCT01731496?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.